Abstract
Stratum corneum (SC), the outermost layer of the skin, constitutes an excellent protective physiological barrier, and is the main challenge in transdermal drug delivery. Many approaches have been used to enhance the penetration of drugs through this layer, covering passive and active methods or the combination of both. This opens the opportunity to broaden the spectrum of drugs that can be administered through the skin, providing alternatives to existing products, and filling gaps that conventional routes failed to occupy. In this review, an overview of the different permeation enhancing methodologies is carried out, focusing on the combination of lipid nanoparticles with conventional chemical enhancers, as a proof-of-concept of a successful development strategy.
Keywords: Active methods, chemical penetration enhancers, lipid nanoparticles, microneedles, passive methods, permeation enhancement, transdermal delivery.
Current Pharmaceutical Design
Title:Overcoming the Skin Permeation Barrier: Challenges and Opportunities
Volume: 21 Issue: 20
Author(s): Carla Vitorino, Joao Sousa and Alberto Pais
Affiliation:
Keywords: Active methods, chemical penetration enhancers, lipid nanoparticles, microneedles, passive methods, permeation enhancement, transdermal delivery.
Abstract: Stratum corneum (SC), the outermost layer of the skin, constitutes an excellent protective physiological barrier, and is the main challenge in transdermal drug delivery. Many approaches have been used to enhance the penetration of drugs through this layer, covering passive and active methods or the combination of both. This opens the opportunity to broaden the spectrum of drugs that can be administered through the skin, providing alternatives to existing products, and filling gaps that conventional routes failed to occupy. In this review, an overview of the different permeation enhancing methodologies is carried out, focusing on the combination of lipid nanoparticles with conventional chemical enhancers, as a proof-of-concept of a successful development strategy.
Export Options
About this article
Cite this article as:
Vitorino Carla, Sousa Joao and Pais Alberto, Overcoming the Skin Permeation Barrier: Challenges and Opportunities, Current Pharmaceutical Design 2015; 21 (20) . https://dx.doi.org/10.2174/1381612821666150428124053
DOI https://dx.doi.org/10.2174/1381612821666150428124053 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Application of Cyclosporine A to Investigate Skeletal Muscle Adaptation
Current Enzyme Inhibition Clinical Use and Patentability of Cord Blood
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Cardiac Remodeling and Exercise Training in Hypertension
Current Hypertension Reviews In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking
Medicinal Chemistry Role of Insulin and Growth Hormone/Insulin-Like Growth Factor-I Signaling in Lifespan Extension: Rodent Longevity Models for Studying Aging and Calorie Restriction
Current Genomics GIP-Based Therapeutics for Diabetes and Obesity
Current Chemical Biology A Broad Variety of Antigens Contribute to the Pathogenesis of Atherosclerosis: How to Neutralize Noxious Reactions in the Host
Endocrine, Metabolic & Immune Disorders - Drug Targets The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured
Endocrine, Metabolic & Immune Disorders - Drug Targets Natural Substances in the Treatment of Cystic Fibrosis
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Development of Chemical Compound Libraries for In Silico Drug Screening
Current Computer-Aided Drug Design The Molecular Basis of Susceptibility to Infection in Liver Cirrhosis
Current Medicinal Chemistry Neuroprotective Effects of <i>Nardostachys jatamansi</i> Against BSO Induced Anxiety via its Antioxidant Machinery and by Elevating Catecholamines and GABA levels in Mice
Current Traditional Medicine Recents Patents for Isolating, Delivering and Tracking Adult Stem Cells in Regenerative Medicine
Recent Patents on Drug Delivery & Formulation Targeted Delivery of Growth Factors by HSV-Mediated Gene Transfer for Peripheral Neuropathy
Current Gene Therapy Insulin- and Growth Factor-Resistance Impairs Vascular Regeneration in Diabetes Mellitus
Current Vascular Pharmacology New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design The Interrelationship Between Disease and Ageing and the Implications for Longevity
Current Aging Science Contribution of Platelet-Derived CD40 Ligand to Inflammation, Thrombosis and Neoangiogenesis
Current Medicinal Chemistry Metabolic and Cardiovascular Ageing Indices in Relation to Glycated Haemoglobin in Healthy and Diabetic Subjects
Current Aging Science Efficacy and Safety Outcomes of Short Duration Antiplatelet Therapy with Early Cessation of Aspirin Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
Current Cardiology Reviews